These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31139078)

  • 1. CYP2J2
    Ahmed JH; Makonnen E; Yimer G; Seifu D; Bekele A; Assefa M; Aseffa A; Howe R; Fotoohi A; Hassan M; Aklillu E
    Front Pharmacol; 2019; 10():481. PubMed ID: 31139078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Anthracycline-Based Chemotherapy-Induced Adverse Drug Reactions and Their Impact on Relative Dose Intensity among Women with Breast Cancer in Ethiopia: A Prospective Observational Study.
    Gadisa DA; Assefa M; Tefera GM; Yimer G
    J Oncol; 2020; 2020():2636514. PubMed ID: 32148494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative Dose Intensity of Chemotherapy and Survival in Patients with Advanced Stage Solid Tumor Cancer: A Systematic Review and Meta-Analysis.
    Nielson CM; Bylsma LC; Fryzek JP; Saad HA; Crawford J
    Oncologist; 2021 Sep; 26(9):e1609-e1618. PubMed ID: 33973301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy.
    Shayne M; Culakova E; Wolff D; Poniewierski MS; Dale DC; Crawford J; Lyman GH
    Cancer; 2009 Nov; 115(22):5319-28. PubMed ID: 19672945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy.
    Shayne M; Culakova E; Poniewierski MS; Wolff D; Dale DC; Crawford J; Lyman GH
    Cancer; 2007 Oct; 110(7):1611-20. PubMed ID: 17705197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non-Small Cell Lung Cancer.
    Tang C; Lee MS; Gomez D; Levy LB; Zhuang Y; Lu C; Liao Z; Komaki R
    Am J Clin Oncol; 2017 Dec; 40(6):625-630. PubMed ID: 26165417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy Dose Intensity and Overall Survival Among Patients With Advanced Breast or Ovarian Cancer.
    Denduluri N; Lyman GH; Wang Y; Morrow PK; Barron R; Patt D; Bhowmik D; Li X; Bhor M; Fox P; Dhanda R; Saravanan S; Jiao X; Garcia J; Crawford J
    Clin Breast Cancer; 2018 Oct; 18(5):380-386. PubMed ID: 29622384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to Cancer Treatment and Chemotherapy Relative Dose Intensity for Patients With Breast Cancer Living With HIV.
    O'Neil DS; Martei YM; Crew KD; Castillo BS; Costa P; Lim T; Michel A; Rubin E; Goel N; Hurley J; Lopes G; Antoni MH
    JAMA Netw Open; 2023 Dec; 6(12):e2346223. PubMed ID: 38051529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial.
    Sedrak MS; Sun CL; Ji J; Cohen HJ; Gross CP; Tew WP; Klepin HD; Wildes TM; Dotan E; Freedman RA; O'Connor T; Chow S; Fenton MA; Moy B; Chapman AE; Dale W; Katheria V; Kuderer NM; Lyman GH; Magnuson A; Muss HB
    J Clin Oncol; 2023 Jan; 41(2):316-326. PubMed ID: 36455189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative dose intensity as a proxy measure of quality and prognosis in adjuvant chemotherapy for breast cancer in daily clinical practice.
    Schraa SJ; Frerichs KA; Agterof MJ; Hunting JCB; Los M; de Jong PC
    Eur J Cancer; 2017 Jul; 79():152-157. PubMed ID: 28494406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study.
    Lyman GH; Dale DC; Friedberg J; Crawford J; Fisher RI
    J Clin Oncol; 2004 Nov; 22(21):4302-11. PubMed ID: 15381684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative dose intensity in early stage breast cancer chemotherapy: A retrospective analysis of incidence, risk factors and outcomes at a south-west Sydney cancer clinic.
    Sandy J; Della-Fiorentina S
    Asia Pac J Clin Oncol; 2013 Dec; 9(4):365-72. PubMed ID: 23937317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy.
    Shayne M; Crawford J; Dale DC; Culakova E; Lyman GH;
    Breast Cancer Res Treat; 2006 Dec; 100(3):255-62. PubMed ID: 16705366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices.
    Lyman GH; Dale DC; Crawford J
    J Clin Oncol; 2003 Dec; 21(24):4524-31. PubMed ID: 14673039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of relative dose intensity in patients with non-Hodgkin lymphoma receiving CHOP-based chemotherapy and pegfilgrastim.
    Balducci L; Mo M; Abella E; Saven A
    Am J Clin Oncol; 2014 Dec; 37(6):603-10. PubMed ID: 25350463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective evaluation of chemotherapy dose intensity and supportive care for early-stage breast cancer in a curative setting.
    Lyman GH; Dale DC; Tomita D; Whittaker S; Crawford J
    Breast Cancer Res Treat; 2013 Jun; 139(3):863-72. PubMed ID: 23771731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of pegfilgrastim to support neoadjuvant dose-dense epirubicin and cyclophosphamide chemotherapy in breast cancer.
    Wang X; He Y; Wang T; Xie Y; Li J; Ouyang T; Fan Z
    Support Care Cancer; 2019 Aug; 27(8):3019-3025. PubMed ID: 30607682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer.
    Yuan Y; Vora N; Sun CL; Li D; Soto-Perez-de-Celis E; Mortimer J; Luu TH; Somlo G; Waisman J; Smith D; Chao J; Katheria V; Synold T; Tran V; Mi S; Levi A; Arsenyan A; Choi J; Zavala L; Yost S; Hurria A
    Breast Cancer Res; 2017 Aug; 19(1):101. PubMed ID: 28851415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of early-stage breast cancer patients treated with sequential anthracyclines-taxanes in relationship to relative dosing intensity: a secondary analysis of a randomized controlled trial.
    Abdel-Rahman O
    Clin Transl Oncol; 2019 Feb; 21(2):239-245. PubMed ID: 29956074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintaining Dose Intensity of Adjuvant Chemotherapy in Older Patients With Breast Cancer.
    Ladwa R; Kalas T; Pathmanathan S; Woodward N; Wyld D; Sanmugarajah J
    Clin Breast Cancer; 2018 Oct; 18(5):e1181-e1187. PubMed ID: 29778788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.